Immunoscintigraphy of Venous Thrombi: Clinical Effectiveness of a New Antifibrin D-Dimer Monoclonal Antibody

Abstract

Safety and thrombus imaging capabilities of the ^99mTc-labeled form of a new F(ab')₂ monoclonal antibody (MoAb) against fragment D dimers from cross-linked human fibrin, previously shown to be effective labeled to ¹³¹I in detecting venous thrombi in the rabbit, were investigated.

Sixteen patients (seven men, mean age: 60 ± 7 years) with deep (n = three) and superficial (n= 13) venous thromboses of the lower limbs documented at echo-Doppler study underwent, 24 hours before saphenous vein stripping, a scintigraphic study after IV injection of the ^99mTc-MoAb (1,129 ± 275 MBq/mL), acquiring dynamic images, as well as early and delayed static images of lower limbs. Tracer activity was compared in normal and pathologic areas. At the operation, vessel wall including the thrombotic lesion was isolated, weighed, and counted. Blood radioactivity and MoAb concentra tion were also measured.

No adverse reaction was observed after MoAb administration. Thrombus site appeared as a focal area (hot spot) of asymmetrically increased tracer uptake, already detectable at early images in all patients. All thrombi detected at echo-Doppler study (n=25) were confirmed at scintigraphic study, which showed four additional hot spots subsequently confirmed to represent thrombi at operation. Average percent ratio between pathologic and normal regions was 1.51 ± 1.34 (p < 0.05) at time-activity curves, 2.27 ± 1.1 (p < 0.05) at early static images, and 2.15 ± 1.2 (p < 0.05) at delayed images, respectively. Thrombus-to-blood uptake ratio was 4.3 ± 0.9 (p < 0.01).

The F(ab')₂ MoAb proved to be safe, and low levels of antimouse antibodies were detected in response, although further studies are needed to assess tolerance and effec tiveness in case of a second administration in the same patient. The ^99mTc-labeled MoAb was very effective in identifying venous thromboses both at deep and superficial local izations, although its sensitivity and specificity need be evaluated in a more numerous group, including also patients with different and clinically more relevant localizations, such as caval thromboses. However, the possibility of obtaining high-quality images within 4 hours of MoAb administration is clinically relevant, and carries also therapeutic implications, especially in pulmonary thromboembolism.

Get full access to this article

View all access options for this article.

References

Kakkar W. , Nicolaides AN , Renny JT : Iodine-125-labelled fibrinogen test adapted for routine screening for deep-vein thromboses. Lancet 1:540, 1970.

Knight LC , Primeau JL , Siegel BA , et al: Comparison of In-111-labeled platelets and iodinated fibrinogen for the detection of deep vein thromboses. J Nucl Med 19:391-394, 1978.

Ezekowitz MD , Pope CF , Sostman HD : Indium-111 platelet scintigraphy for the diagnosis of acute vein thrombosis. Circulation 73:668-674, 1986.

Knight LC : Scintigraphic methods for detecting vascular thrombus. J Nucl Med 34:554-561, 1993.

Hui KY , Haber E. , Matsueda GR : Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not to fibrinogen. Science 222:1129-1132, 1983.

Kudryk B. , Rohoza A. , Ahadi M. , et al: Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol 21:89-94, 1984.

Scopinaro F. , Di Loreto M. , Banci M. , et al: Anti D dimer monoclonal antibodies: A possible scintigraphic agent for immunodetection of thrombi. Nucl Med Commun 13:723-729, 1992.

Greco C. , Di Loreto M. , Ciavolella M. , et al: Immunodetection of human atherosclerotic plaque with 125I-labeled monoclonal antifibrin antibodies. Atherosclerosis 100:133-138, 1993.

Bettmann MA , Robbins A. , Braun SD , et al: Contrast venography of the leg: Diagnostic efficacy, tolerance, and complication rates with ionic and nonionic contrast media. Radiology 165:113-126, 1987.

10.

Foley WD , Middleton WD , Lawson TL , et al: Color-Doppler ultrasound imaging of lower-extremity venous disease . Am J Roentgenol 152:371-379, 1989.

11.

Scheefers-Borchel U. , Muller-Berghaus G. , Fuhge P. : Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide. Proc Natl Acad Sci USA 82:7091-7095, 1985.

12.

Gargan PE , Ploplis VA , Scheu JD : A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of the tissue plasminogen activator. Thromb Haemost 59:426-431, 1988.

13.

Rosebrough SF , McAfee JG , Grossman ZD , et al: Immunoreactivity of 111In and 131I fibrin-specific monoclonal antibody used for thrombus imaging . J Immunol Methods 116:123-129, 1989.

14.

Rylatt DB , Blake AS , Scottis LE : An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 31:767-772, 1983.

15.

Holvoet P. , Stassen JM , Hashimoto Y. , et al: Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits. Thromb Haemost 61:307-313, 1989.

16.

Bautovich G. , Angelides S. , Lee F-T. , et al: Detection of deep venous thrombi and pulmonary embolus with Technetium-99m-DD-3B6/22 anti-fibrin monoclonal antibody Fab' fragment. J Nucl Med 35:195-202, 1994.

17.

Stratton JR , Cerqueira MD , Dewhurst A. , et al: Imaging arterial thrombosis: Comparison of Technetium-99m-labeled monoclonal antifibrin antibodies and Indium-111-platelets . J Nucl Med 35:1731-1737, 1994 .

18.

Scopinaro F. , Tavolaro R. , Ciavolella M. , et al: 99mTc anti-D dimer MoAb detects venous thrombi in man (abstract). Eur J Nucl Med 23:1064, 1996.

19.

Tavolaro R. , Scopinaro F. , Ciavolella M. , et al: Localization of venous and arterial thrombi with 99mTc anti-D dimer monoclonal antibodies in man (abstract). Q J Nucl Med 40 (suppl 1):34, 1996.